Central and Eastern European countries have clamored to revise the terms of the deal.
The European Commission and U.S. pharmaceutical giant Pfizer have renegotiated a massive contract for COVID-19 vaccine doses that the EU entered into at the height of the pandemic.
The Commission announced that the two parties had agreed Pfizer would spread out deliveries over the course of the next four years, into 2027, and to reduce the total amount of doses down from the 450 million that were due to be delivered this year. However, the Commission didn’t disclose the new total in its announcement. When asked by POLITICO about the revised delivery figure, Commission Health Spokesperson Stefan de Keersmaecker referred POLITICO to EU member countries for a response.
“Vaccine strategies or vaccine programs are designed and implemented by the member states,” said de Keersmaecker.